Center Care (Meritain) policies, page 97

Search Center Care (Meritain)'s public medical, payment and drug policies by CPT or HCPCS code, keyword or policy number, with links to the payer's own documents. Links open the payer's own document; check its current version before relying on it.

5,481 public policies Substrate tracks for Center Care (Meritain), by title.

Center Care (Meritain) policies
PolicyDetailsCodesSource
Enbrel 2003-A SGM P2020a2003-A SGM P2020a · Commercial—Original policy ↗
Endari 2208-A SGM P20232208-A · Commercial—Original policy ↗
Endolymphatic Hydrops (Meniere's Disease) Tests0571 · Commercial10Original policy ↗
Endometrial Cancer Screening, Diagnosis, and Prognosis0769 · Commercial21Original policy ↗
Endoscopic Ultrasonography0446 · Commercial31Original policy ↗
Endovascular Arterial and Venous Stent Procedures0785 · Commercial21Original policy ↗
Endovascular Repair of Aortic Diseases0651 · Commercial40Original policy ↗
Enfortumab Vedotin-ejfv (Padcev)0967 · Commercial21Original policy ↗
Enhanced External Counterpulsation (EECP)0262 · Commercial22Original policy ↗
entecavir-Baraclude Supplemental Specialty PA 4779-A P20264779-A P2026 · Commercial—Original policy ↗
Enuresis0431 · Commercial19Original policy ↗
Epilepsy Surgery0394 · Commercial84Original policy ↗
Epogen-Procrit-Retacrit 1619-A SGM P20211619-A · Commercial—Original policy ↗
epoprostenol-Flolan-Veletri SGM 1642-A P20251642-A · Commercial—Original policy ↗
Erectile Dysfunction and Peyronie's Disease0007 · Commercial111Original policy ↗
Esbriet 1881-A SGM P20221881-A · Commercial—Original policy ↗
Etanercept0315 · Commercial39Original policy ↗
Ethanol Injection for Thyroid Lesions and Other Selected Indications0395 · Commercial5Original policy ↗
Eucrisa ST with Limit, Post PA (Aetna SG ACA, Aetna IVL, MF Only) 3199-E P04-20263199-E · Commercial—Original policy ↗
everolimus-Afinitor Products 2021-A SGM P2022P2022 · Commercial—Original policy ↗
Evzio, Kloxxado, Narcan, Zimhi Limit Policy 1137-H 02-2022 v21137-H · Commercial—Original policy ↗
Extina Limit, Post PA Policy 2948-HJ UDR 04-20232948-HJ · Commercial—Original policy ↗
Extracorporeal Immunoadsorption (Prosorba Column)0355 · Commercial6Original policy ↗
Extracorporeal Membrane Oxygenation (ECMO)0546 · Commercial72Original policy ↗
Extracorporeal Shock-Wave Therapy for Musculoskeletal Indications and Soft Tissue Injuries0649 · Commercial6Original policy ↗
Eye Movement Desensitization and Reprocessing (EMDR) Therapy0583 · Commercial2Original policy ↗
Eye Prosthesis0619 · Commercial9Original policy ↗
Eysuvis PA with Limit Policy 4348-C UDR 11-20234348-C · Commercial—Original policy ↗
Fabhalta SGM 6288-A P2025a6288-A · Commercial—Original policy ↗
Fabrazyme 2054-A SGM P20212054-A · Commercial—Original policy ↗
Facial Nerve Paralysis0745 · Commercial73Original policy ↗
Facial Prostheses, External0620 · Commercial35Original policy ↗
Factor IX Complex SGM 1949-A P20251949-A · Commercial—Original policy ↗
Factor VIII 1937-A, 1938-A, 1946-A, 1939-A, 1945-A, 2688-A SGM P20221937-A, 1938-A, 1946-A, 1939-A, 1945-A, 2688-A · Commercial—Original policy ↗
Fecal Incontinence0611 · Commercial62Original policy ↗
Female Condoms Limit, Post PA Policy 4702-HJ UDR 04-20244702-HJ · Commercial—Original policy ↗
Female Sexual Dysfunction (FSD)0574 · Commercial30Original policy ↗
Fetal Surgery In Utero0449 · Commercial13Original policy ↗
Firdapse 2803-A SGM P20232803-A · Commercial—Original policy ↗
Firdapse 2803-A SGM P20232803-A · Commercial—Original policy ↗
Flector, Licart Limit 349-H P06-2024_R349-H · Commercial—Original policy ↗
Flow Cytometry, Ektacytometry, DNA Ploidy, and S-phase Fraction0351 · Commercial13Original policy ↗
Fluidized Therapy (Fluidotherapy)0450 · Commercial2Original policy ↗
Follitropins 1914-A, 1915-A SGM P20241914-A, 1915-A · Commercial—Original policy ↗
Foot Orthotics0451 · Commercial22Original policy ↗
Forteo-Teriparatide-Bonsity 2028-A SGM P2022a2028-A SGM P2022a · Commercial—Original policy ↗
Foundayo Exception (VF VFC) 7434-A 04-2026 v27434-A · Commercial—Original policy ↗
Frenectomy or Frenotomy for Ankyloglossia0116 · Commercial8Original policy ↗
fulvestrant-Faslodex 2903-A SGM P20222903-A · Commercial—Original policy ↗
Functional Electrical Stimulation and Neuromuscular Electrical Stimulation0677 · Commercial67Original policy ↗

Back to Center Care (Meritain)

Disclaimer

The information provided on this page is for general informational purposes only and does not constitute billing, coding, or reimbursement advice. Nothing on this page should be relied upon as a substitute for clinician assessment, professional billing guidance, or as a definitive statement of any payor's billing requirements or policies.

Payor agreements, fee schedules, and billing policies vary and are subject to change. Before submitting any claims related to maternity care services, including claims affected by the 2027 CPT code revisions, please consult the applicable payor agreements, coverage policies, and billing guidelines to confirm current requirements for their specific payor contracts.

Substrate makes no representation or warranty regarding the accuracy, completeness, or timeliness of the payor-specific information presented here. Providers are solely responsible for ensuring that all claims are submitted in accordance with applicable payor requirements, and Substrate assumes no liability for claim denials, underpayments, or other adverse outcomes arising from reliance on this information.